These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26098330)

  • 1. Benefits from invasive treatment in intermittent claudication: It is definitely not IRONIC!
    Freisinger E; Reinecke H
    Vasa; 2015 May; 44(3):240. PubMed ID: 26098330
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments regarding 'Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial'.
    Dryjski ML
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):228-9. PubMed ID: 21531592
    [No Abstract]   [Full Text] [Related]  

  • 3. A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication.
    Ahimastos AA; Pappas EP; Buttner PG; Walker PJ; Kingwell BA; Golledge J
    J Vasc Surg; 2011 Nov; 54(5):1511-21. PubMed ID: 21958561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial.
    Nordanstig J; Gelin J; Hensäter M; Taft C; Österberg K; Jivegård L
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):220-7. PubMed ID: 21397530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data, guidelines, and practice of revascularization for claudication.
    Conte MS
    J Vasc Surg; 2017 Sep; 66(3):911-915. PubMed ID: 28842076
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment for intermittent claudication and the effects on walking distance and quality of life.
    Kruidenier LM; Viechtbauer W; Nicolaï SP; Büller H; Prins MH; Teijink JA
    Vascular; 2012 Feb; 20(1):20-35. PubMed ID: 22271802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative therapy in patients with intermittent claudication.
    Minar E
    Vasa; 2015 Mar; 44(2):85-91. PubMed ID: 25698386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "What is the place of surgery for intermittent claudication?".
    Jivegård L; Gelin J; Nordanstig J; Österberg K; Taft C
    Eur J Vasc Endovasc Surg; 2011 Feb; 41(2):294; author reply 294-5. PubMed ID: 21126891
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk attitudes to treatment among patients with severe intermittent claudication.
    Letterstål A; Forsberg C; Olofsson P; Wahlberg E
    J Vasc Surg; 2008 May; 47(5):988-94. PubMed ID: 18455642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part two: against the motion. endovascular therapy is the preferred treatment for patients <65 years old with symptomatic infrainguinal arterial disease.
    Houbballah R; Raux M; LaMuraglia G
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):116-9. PubMed ID: 22878046
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Cochrane library: Ginkgo biloba for intermittent claudication.
    Nicolaï SP; Gerardu VC; Kruidenier LM; Prins MH; Teijink JA
    Vasa; 2010 May; 39(2):153-8. PubMed ID: 20464671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication.
    Tan LT; McDermott KM; Hicks CW
    Semin Vasc Surg; 2024 Jun; 37(2):188-209. PubMed ID: 39151998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and functional status after revascularization or conservative treatment in patients with intermittent claudication.
    Hedeager Momsen AM; Bach Jensen M; Norager CB; Roerbæk Madsen M; Vestersgaard-Andersen T; Lindholt JS
    Vasc Endovascular Surg; 2011 Feb; 45(2):122-9. PubMed ID: 21278180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised exercise therapy for intermittent claudication in daily practice.
    Kruidenier LM; Nicolaï SP; Hendriks EJ; Bollen EC; Prins MH; Teijink JA
    J Vasc Surg; 2009 Feb; 49(2):363-70. PubMed ID: 19028059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of claudication and its treatment on quality of life.
    Spronk S; White JV; Bosch JL; Hunink MG
    Semin Vasc Surg; 2007 Mar; 20(1):3-9. PubMed ID: 17386358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramipril for treatment of intermittent claudication.
    Poredos P
    Vasa; 2013 Jul; 42(4):237-8. PubMed ID: 23823855
    [No Abstract]   [Full Text] [Related]  

  • 17. Editor's choice--The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis.
    Gommans LN; Saarloos R; Scheltinga MR; Houterman S; de Bie RA; Fokkenrood HJ; Teijink JA
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):169-84. PubMed ID: 24928167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease.
    Paumier A; Abraham P; Mahé G; Maugin E; Enon B; Leftheriotis G; Picquet J
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):323-9. PubMed ID: 19910224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus.
    van Pul KM; Kruidenier LM; Nicolaï SP; de Bie RA; Nieman FH; Prins MH; Teijink JA
    Ann Vasc Surg; 2012 Oct; 26(7):957-63. PubMed ID: 22858162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised exercise therapy for intermittent claudication: current status and future perspectives.
    Lauret GJ; van Dalen DC; Willigendael EM; Hendriks EJ; de Bie RA; Spronk S; Teijink JA
    Vascular; 2012 Feb; 20(1):12-9. PubMed ID: 22328620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.